Ibrutinib-Induced Lymphocytosis: Cytological Features

被引：3

作者：

Quintela, Adrien ^{[1
]}

Sujobert, Pierre ^{[2
,3
]}

Callet-Bauchu, Evelyne ^{[2
,3
]}

Salles, Gilles ^{[1
,3
]}

Baseggio, Lucile ^{[2
,3
]}

机构：

[1] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Hematol, Pierre Benite, France

[2] Univ Claude Bernard, Lab Hematol Cellulaire, Lyon, France

[3] Univ Claude Bernard, INSERM U1052, CNRS UMR5286, Lyon, France

来源：

ACTA HAEMATOLOGICA | 2017年 / 137卷 / 01期

关键词：

SMUDGE CELLS; LEUKEMIA; SURVIVAL;

D O I：

10.1159/000452437

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：55 / 57

页数：3

共 9 条

[1] Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib [J].

Byrd, John C. ;

Furman, Richard R. ;

Coutre, Steven E. ;

Burger, Jan A. ;

Blum, Kristie A. ;

Coleman, Morton ;

Wierda, William G. ;

Jones, Jeffrey A. ;

Zhao, Weiqiang ;

Heerema, Nyla A. ;

Johnson, Amy J. ;

Shaw, Yun ;

Bilotti, Elizabeth ;

Zhou, Cathy ;

James, Danelle F. ;

O'Brien, Susan .

BLOOD, 2015, 125 (16) :2497-2506

[2] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[3] Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study [J].

Herman, S. E. M. ;

Niemann, C. U. ;

Farooqui, M. ;

Jones, J. ;

Mustafa, R. Z. ;

Lipsky, A. ;

Saba, N. ;

Martyr, S. ;

Soto, S. ;

Valdez, J. ;

Gyamfi, J. A. ;

Maric, I. ;

Calvo, K. R. ;

Pedersen, L. B. ;

Geisler, C. H. ;

Liu, D. ;

Marti, G. E. ;

Aue, G. ;

Wiestner, A. .

LEUKEMIA, 2014, 28 (11) :2188-2196

[4]

KJELDSBERG CR, 1981, CANCER-AM CANCER SOC, V48, P2447, DOI 10.1002/1097-0142(19811201)48:11<2447::AID-CNCR2820481118>3.0.CO

[5]

2-B

[6] Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: A universally available prognostic test [J].

Nowakowski, Grzegorz S. ;

Hoyer, James D. ;

Shanafelt, Tait D. ;

Geyer, Susan M. ;

LaPlant, Betsy R. ;

Call, Timothy G. ;

Jelinek, Diane F. ;

Zent, Clive S. ;

Kay, Neil E. .

MAYO CLINIC PROCEEDINGS, 2007, 82 (04) :449-453

[7] Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia [J].

Nowakowski, Grzegorz S. ;

Hoyer, James D. ;

Shanafelt, Tait D. ;

Zent, Clive S. ;

Call, Timothy G. ;

Bone, Nancy D. ;

LaPlant, Betsy ;

Dewald, Gordon W. ;

Tschumper, Renee C. ;

Jelinek, Diane F. ;

Witzig, Thomas E. ;

Kay, Neil E. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) :1844-1849

[8] The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo [J].

Ponader, Sabine ;

Chen, Shih-Shih ;

Buggy, Joseph J. ;

Balakrishnan, Kumudha ;

Gandhi, Varsha ;

Wierda, William G. ;

Keating, Michael J. ;

O'Brien, Susan ;

Chiorazzi, Nicholas ;

Burger, Jan A. .

BLOOD, 2012, 119 (05) :1182-1189

[9] Lymphocytosis and ibrutinib treatment of CLL [J].

Rossi, Davide ;

Gaidano, Gianluca .

BLOOD, 2014, 123 (12) :1772-1774

← 1 →